Alliancebernstein L.P. Athenex, Inc. Transaction History

Alliancebernstein L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $0.91 $33,907 - $75,257	-82,700 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.79 - $1.59 $8,137 - $16,377	-10,300 Reduced 11.08%	82,700 $69,000
Q2 2021 Jul 30, 2021	BUY	$3.71 - $5.13 $56,021 - $77,463	15,100 Added 19.38%	93,000 $430,000
Q4 2020 Feb 08, 2021	SELL	$11.06 - $14.01 $64,148 - $81,258	-5,800 Reduced 6.93%	77,900 $862,000
Q3 2020 Nov 12, 2020	SELL	$10.26 - $14.55 $92,340 - $130,950	-9,000 Reduced 9.71%	83,700 $1.01 Million
Q2 2020 Aug 13, 2020	BUY	$7.11 - $13.76 $100,962 - $195,392	14,200 Added 18.09%	92,700 $1.28 Million
Q1 2020 May 14, 2020	SELL	$5.71 - $15.85 $11,420 - $31,700	-2,000 Reduced 2.48%	78,500 $608,000
Q4 2019 Feb 18, 2020	BUY	$9.6 - $17.75 $19,200 - $35,500	2,000 Added 2.55%	80,500 $1.23 Million
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $257,712 - $540,540	27,300 Added 53.32%	78,500 $1.55 Million
Q2 2018 Aug 13, 2018	BUY	$15.88 - $19.5 $590,736 - $725,400	37,200 Added 265.71%	51,200 $955,000
Q1 2018 May 14, 2018	BUY	$13.53 - $17.47 $189,420 - $244,579	14,000 New	14,000 $238,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.